Teplizumab Resource Portal

The information contained within this portal is designed to help clinicians with the application of teplizumab for type 1 diabetes (T1D), including considerations prior to, during, and after infusions, as well as practical resources to facilitate the administration of this treatment option to eligible patients. In addition, the portal provides resources for patients and caregivers who have been identified and confirmed as being eligible to receive this therapy, or that are considering treatment with teplizumab. The portal focuses on teplizumab as it is the only disease-modifying therapy that is clinically available to date. For other agents in development, please visit other sections of the DETECT-T1D website.

We have partnered with the National Infusion Center Association (NICA) to provide additional resources to clinicians and patients, including a teplizumab infusion center locator tool, as well as several downloadable resources (located in the resource section).